Stay updated on Benralizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page
- Check5 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.0%

- Check13 days agoChange DetectedIQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed from the Collaborators and Investigators section. This updates the official list of organizations involved in the study.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.2 was added to the page. The government funding status notice and the prior revision notice for v3.4.1 were removed.SummaryDifference0.3%

- Check77 days agoChange DetectedA site-wide government funding status notice was added, stating that information may not be up to date and where to check for updates. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.